BRAINAURORA-B Maintains Stable Share Base in May 2026, Confirms Public Float Compliance

Bulletin Express06-02

BrainAurora Medical Technology Limited (BRAINAURORA-B) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited on 02 June 2026, covering the month ended 31 May 2026. Key disclosures are as follows:

• Authorised share capital stayed unchanged at 500.00 billion ordinary shares with a par value of USD 0.0000001 each, amounting to total authorised capital of USD 50,000.

• Issued share capital remained steady at 1.36 billion ordinary shares. No new shares were issued, repurchased, or cancelled during the month, and the company continues to hold zero treasury shares.

• The company confirmed that it met the Main Board’s minimum public-float requirement of 25% as of 31 May 2026.

• No outstanding share options, warrants, convertible securities, or other equity-linked instruments were reported for the period.

The filing indicates that BRAINAURORA-B’s capital structure and share count were unchanged in May, and its free-float level remains compliant with Hong Kong listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment